(Q3)Jul 28, 2024 | (Q2)Apr 28, 2024 | (Q1)Jan 28, 2024 | (FY)Oct 29, 2023 | (Q4)Oct 29, 2023 | (Q3)Jul 30, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 29, 2023 | (FY)Oct 30, 2022 | (Q4)Oct 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 5.00%3.2B | 68.52%1.85B | 27.13%-908M | 82.78%8.59B | 32.98%5.69B | 39.59%3.04B | 38.94%1.1B | 51.19%-1.25B | -39.18%4.7B | 25.47%4.28B |
Net income from continuing operations | -41.79%1.73B | -17.14%2.37B | -10.68%1.75B | 42.43%10.16B | 5.53%2.37B | 57.67%2.97B | 36.29%2.86B | 116.48%1.96B | 19.53%7.13B | 74.90%2.24B |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---326M | --0 |
Depreciation and amortization | 3.95%553M | 4.79%525M | 5.26%520M | 5.75%2B | 5.53%477M | 4.31%532M | 12.08%501M | 1.65%494M | -7.56%1.9B | -6.03%452M |
Asset impairment expenditure | ---- | ---- | ---- | 117.05%191M | 157.14%18M | ---- | ---- | ---- | 76.00%88M | --7M |
Remuneration paid in stock | 264.00%91M | 143.90%100M | 123.85%31M | -108.33%-16M | -63.08%48M | 47.06%25M | --41M | ---130M | 3,300.00%192M | 1,081.82%130M |
Remuneration paid in stock | -5.17%55M | 87.10%58M | 100.00%46M | 52.94%130M | -14.29%18M | 190.00%58M | 19.23%31M | 27.78%23M | 3.66%85M | 16.67%21M |
Deferred tax | 90.38%-5M | 54.21%-147M | 148.21%27M | -1,096.97%-790M | -501.67%-361M | -20.93%-52M | -85.55%-321M | -126.67%-56M | 85.03%-66M | 64.71%-60M |
Other non cashItems | -75.86%-255M | -33.33%90M | -103.76%-7M | 1,475.00%252M | 371.43%76M | -167.44%-145M | 189.40%135M | 1,030.00%186M | 104.32%16M | 62.67%-28M |
Change In working capital | 287.12%973M | 46.78%-1.14B | 12.02%-3.27B | 22.67%-3.34B | 101.25%3.05B | -21.50%-520M | -71.54%-2.15B | 10.38%-3.72B | -1,189.65%-4.32B | -18.90%1.52B |
-Change in receivables | 103.53%23M | 35.38%-2.19B | 72.71%-277M | -71.28%-4.25B | 739.68%806M | 20.68%-652M | -137.37%-3.39B | -857.55%-1.02B | -356.24%-2.48B | -108.92%-126M |
-Change in inventory | 101.57%643M | 5.72%314M | 43.47%-723M | 113.34%279M | 116.55%942M | 222.22%319M | 130.68%297M | 1.39%-1.28B | 16.26%-2.09B | 163.97%435M |
-Change in payables and accrued expense | -20.83%285M | -18.75%1.03B | -47.56%-2.33B | -26.74%830M | -31.79%783M | -15.89%360M | 13.77%1.26B | -1.48%-1.58B | -39.86%1.13B | 0.53%1.15B |
-Change in other working capital | 104.02%22M | 7.62%-291M | -64.24%54M | 77.92%-193M | 793.10%518M | -340.97%-547M | -1,000.00%-315M | 112.65%151M | -2,285.00%-874M | 928.57%58M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 5.00%3.2B | 68.52%1.85B | 27.13%-908M | 82.78%8.59B | 32.98%5.69B | 39.59%3.04B | 38.94%1.1B | 51.19%-1.25B | -39.18%4.7B | 25.47%4.28B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 34.80%-2B | -28.08%-2.89B | 60.13%1.22B | -3.11%-8.75B | -3.23%-4.19B | -20.73%-3.07B | 11.12%-2.25B | 17.28%760M | -47.57%-8.49B | -53.13%-4.06B |
Net PPE purchase and sale | -15.25%-680M | -51.88%-767M | 1.59%-310M | -46.73%-2.49B | -21.97%-1.08B | -18.71%-590M | -140.48%-505M | -200.00%-315M | -248.77%-1.7B | -200.34%-883M |
Net business purchase and sale | ---- | ---- | ---- | 83.53%-82M | ---- | ---- | ---- | ---- | -104.10%-498M | 95.56%-10M |
Net investment purchase and sale | -275.00%-7M | ---- | ---- | ---- | ---- | --4M | ---- | ---- | ---- | ---- |
Net other investing changes | 47.08%-1.31B | -13.80%-1.89B | 42.05%1.53B | 1.78%-6.18B | 1.55%-3.11B | -22.32%-2.48B | 11.61%-1.66B | 38.35%1.08B | -25.34%-6.29B | -48.52%-3.16B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 34.80%-2B | -28.08%-2.89B | 60.13%1.22B | -3.11%-8.75B | -3.23%-4.19B | -20.73%-3.07B | 11.12%-2.25B | 17.28%760M | -47.57%-8.49B | -53.13%-4.06B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -72.61%373M | -37.05%1.48B | -680.24%-2.65B | 239.95%2.81B | -283.60%-571M | 51.17%1.36B | 97.82%2.36B | 78.50%-339M | 176.62%826M | 237.00%311M |
Net issuance payments of debt | -58.00%1.62B | -25.07%3.01B | -170.56%-901M | 99.90%11.52B | 32.26%2.37B | 55.21%3.86B | 92.15%4.02B | 311.07%1.28B | 135.31%5.77B | 119.98%1.8B |
Net common stock issuance | 61.97%-805M | 15.13%-1.09B | -5.65%-1.33B | -100.61%-7.22B | -127.95%-2.55B | -62.72%-2.12B | -128.55%-1.29B | -105.39%-1.26B | -41.73%-3.6B | -25.28%-1.12B |
Cash dividends paid | -10.33%-406M | -15.17%-410M | -13.20%-386M | -8.68%-1.43B | -5.85%-362M | -14.29%-368M | -10.56%-356M | -4.28%-341M | -26.25%-1.31B | -22.58%-342M |
Net other financing activities | -260.00%-36M | -46.67%-22M | -66.67%-30M | -151.72%-73M | -36.36%-30M | -125.64%-10M | -15.38%-15M | 45.45%-18M | -158.00%-29M | -116.92%-22M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -72.61%373M | -37.05%1.48B | -680.24%-2.65B | 239.95%2.81B | -283.60%-571M | 51.17%1.36B | 97.82%2.36B | 78.50%-339M | 176.62%826M | 237.00%311M |
Net cash flow | ||||||||||
Beginning cash position | 6.31%5.73B | 26.85%5.3B | 54.22%7.62B | -39.19%4.94B | 51.13%6.78B | 35.39%5.39B | -8.56%4.18B | -39.19%4.94B | 13.29%8.13B | -41.29%4.49B |
Current changes in cash | 17.29%1.57B | -62.70%448M | -183.15%-2.34B | 189.46%2.65B | 74.30%936M | 147.87%1.34B | 316.79%1.2B | 76.31%-825M | -429.62%-2.96B | 0.00%537M |
Effect of exchange rate changes | -101.82%-1M | -362.50%-21M | -74.19%16M | 113.84%31M | -16.05%-94M | 266.67%55M | 122.22%8M | 183.78%62M | -507.27%-224M | -58.82%-81M |
End cash Position | 7.60%7.29B | 6.31%5.73B | 26.85%5.3B | 54.22%7.62B | 54.22%7.62B | 51.13%6.78B | 35.39%5.39B | -8.56%4.18B | -39.19%4.94B | -39.19%4.94B |
Free cash from | 3.70%2.08B | 491.84%580M | 16.23%-1.72B | 352.36%4.12B | 45.40%4.08B | 64.42%2B | 292.00%98M | 34.40%-2.06B | -82.30%911M | 10.73%2.81B |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data